Gallaway Michael Shayne, Idaikkadar Nimi, Tai Eric, Momin Behnoosh, Rohan Elizabeth A, Townsend Julie, Puckett Mary, Stewart Sherri L
Division of Cancer Prevention and Control National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention Atlanta Georgia USA.
Division of Health Informatics and Surveillance Center for Surveillance Epidemiology, and Laboratory Services Centers for Disease Control and Prevention Atlanta Georgia USA.
J Am Coll Emerg Physicians Open. 2021 May 1;2(3):e12438. doi: 10.1002/emp2.12438. eCollection 2021 Jun.
People with cancer are increasingly more likely to visit an emergency department for acute care than the general population. They often have long wait times and more exposure to infection and receive treatment from staff less experienced with cancer-related problems. Our objective was to examine emergency department (ED) visits among people with cancer to understand how often and why they seek care.
We conducted a retrospective study of ED visits using the National Syndromic Surveillance Program BioSense Platform. Cancer reported during an ED visit was identified using codes for any cancer type, including bladder, breast, cervical, colorectal, kidney, liver, lung, ovary, pancreas, prostate, or uterine cancers. Symptoms prompting the visit were identified for people with cancer who visited EDs in the United States from June 2017 to May 2018 in ≈4500 facilities, including 3000 EDs in 46 states and the District of Columbia (66% of all ED visits during a 1-year period).
Of 97 million ED visits examined, 710,297 (0.8%) were among people with cancer. Percentages were higher among women (50.1%) than men (49.5%) and among adults aged ≥65 years (53.6%) than among those ≤64 years (45.7%). The most common presenting symptoms were pain (19.1%); gastrointestinal (13.8%), respiratory (11.5%), and neurologic (5.3%) complaints; fever (4.9%); injury (4.1%); and bleeding (2.4%). Symptom prevalence differed significantly by cancer type.
The Centers for Medicare & Medicaid Services encourages efforts to reduce acute care visits among people with cancer. We characterized almost 70% of ED visits among this population.
与普通人群相比,癌症患者因急性病前往急诊科就诊的可能性越来越大。他们往往等待时间较长,更容易受到感染,而且接受治疗的医护人员对癌症相关问题的经验较少。我们的目的是研究癌症患者的急诊科就诊情况,以了解他们就诊的频率和原因。
我们使用国家症候群监测计划生物传感平台对急诊科就诊情况进行了一项回顾性研究。在急诊科就诊期间报告的癌症通过任何癌症类型的编码来识别,包括膀胱癌、乳腺癌、宫颈癌、结直肠癌、肾癌、肝癌、肺癌、卵巢癌、胰腺癌、前列腺癌或子宫癌。对于2017年6月至2018年5月期间在美国约4500家医疗机构(包括46个州和哥伦比亚特区的3000家急诊科,占1年期间所有急诊科就诊人次的66%)就诊的癌症患者,确定了促使其就诊的症状。
在检查的9700万次急诊科就诊中,710297次(0.8%)是癌症患者。女性(50.1%)的比例高于男性(49.5%),65岁及以上成年人(53.6%)的比例高于64岁及以下人群(45.7%)。最常见的就诊症状是疼痛(19.1%);胃肠道症状(13.8%)、呼吸道症状(11.5%)和神经系统症状(5.3%);发热(4.9%);受伤(4.1%);以及出血(2.4%)。症状患病率因癌症类型而异。
医疗保险和医疗补助服务中心鼓励努力减少癌症患者的急性病就诊次数。我们描述了该人群中近70%的急诊科就诊情况。